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Objectives. We examined the influence of an initial “stent-like”
result on long-term outcome in patients in the 1985–86 NHLBI
PTCA Registry.
Background. Stent use in selected patients is associated with
improved angiographic and short-term clinical outcome; however,
due to potential for in-stent restenosis and high costs of stents,
there is interest in a strategy of more optimal dilatation to achieve
a “stent-like” result without a stent. The long-term outcome of
patients with a “stent-like” percutaneous transluminal coronary
angioplasty (PTCA) remains unknown.
Methods. Ten-year outcome was compared between 225 suc-
cessfully treated patients with and 1,764 successfully treated
patients without an initial “stent-like” result (>21 lesion dilated to
<210% stenosis). The sample had 75% and 80% power, respec-
tively, to detect an absolute difference of 8% in the 10-year rate of
death and myocardial infarction (MI) between the two groups.
Results. Ten-year rates of death and MI were similar between
the stent-like and non–stent-like groups (22.3% vs. 22.2%, 17.6%
vs. 17.9%), however, there was less target lesion revascularization
in the stent-like group (30.2% vs. 36.8%). In subgroup analysis of
patients with multivessel disease, those with a stent-like result
had less follow-up bypass surgery (25.2% vs. 32.7%), yet more
repeat PTCA (53.8% vs. 42.7%). These findings were unaffected by
adjustment for differences in baseline characteristics between the
two patient groups.
Conclusions. Achievement of an initial stent-like result via
balloon angioplasty alone may not appreciably reduce the long-
term risk of death or MI, nor confer equivalent clinical benefit as
achieving a stent-like result with a stent.
(J Am Coll Cardiol 1998;32:590–5)
©1998 by the American College of Cardiology
Compared with conventional balloon angioplasty, coronary
stenting reduces the immediate need for bypass surgery fol-
lowing abrupt vessel closure (1–3) and reduces the short-term
requirement for repeat revascularization (4–7) by achieving a
stable, large lumen (8). Stent implantation does not prevent
neo-intimal hyperplasia, and indeed, probably exaggerates it,
but it is better tolerated because of the large initial gain and
lack of acute recoil (9). Because of the potential for in-stent
restenosis and the high costs of stents, there have been
attempts to optimize conventional coronary angioplasty and
achieve a “stent-like” result without the stent. Early data
(10,11) suggest this results in better outcome compared with
the result of less optimal coronary angioplasty. The long-term
outcome of patients with a “stent-like” result without use of a
stent remains unknown. The purpose of this study is to
compare 10-year outcome in patients with successful dilatation
in the 1985–86 NHLBI PTCA Registry on the basis of whether
or not an initial “stent-like” result was achieved with conven-
tional coronary angioplasty.
Methods
Patient population. Of 2,431 patients from 16 participating
NHLBI PTCA Registry sites, a subset of 1,989 patients who
achieved an initially successful result were considered. An
initially successful coronary angioplasty was defined as at least
one lesion successfully dilated (,50% residual stenosis and
$20% improvement in lumen diameter) and no in-hospital
death, myocardial infarction (MI), or emergency bypass sur-
gery. Eligibility criteria for the Registry and patient character-
istics have been described (12–15). Briefly, consecutive pa-
tients at participating sites were entered at the time of first-
time coronary angioplasty. All patients gave written informed
consent to be contacted annually after the initial procedure to
report health status and intercurrent clinical events. The study
protocol was approved by the Institutional Review Board for
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Biomedical Research at the University of Pittsburgh, Coordi-
nating Center for the Registry. Patient confidentiality was
ensured by the use of alphanumeric codes rather than names.
In this cohort, outcome following successful coronary angio-
plasty was studied on the basis of whether or not an initial
“stent-like” result was achieved.
Definitions. Patients were considered to have achieved a
stent-like result if at least one lesion was successfully dilated to
#10% diameter stenosis, as determined by visual assessment
of multiple orthogonal views by the coronary angioplasty
operator. A non–stent-like result was defined as at least one
lesion dilated to ,50% stenosis with $20% improvement in
lumen diameter, but with no lesions dilated to #10% stenosis.
No routine method of visual reading was required, but at most
clinical centers caliper reading was used to define the percent
stenosis. Approximately 25% of the registry patients had pre-
and post-PTCA angiographic readings centrally reviewed by
use of quantitative coronary angiography (University of Mary-
land) (16); however, to maintain consistency, only visual
assessments were used in the analysis. A review of 294 lesions
with both visual and core laboratory readings revealed that, on
average, the percent stenosis after coronary angioplasty was
about 10% lower in the visual readings than by quantitative
coronary angiography. Our stringent definition of #10% ste-
nosis for a stent-like result, as derived from visual readings, was
selected because of the potential overestimation of lumen gain
from visual readings. Coronary artery lesions were classified by
arterial segments in accordance with definitions in the Coro-
nary Artery Surgery Study (17).
MI was documented by at least two of the following: clinical
symptoms, ECG evidence (Q-wave criteria of a definite MI
according to the Minnesota Code) (18), and enzyme changes
(more than double the upper normal limits of creatine kinase
and/or the presence of creatine kinase-MB). Infarctions after
hospitalization for initial coronary angioplasty were recorded
whether they occurred alone, during a repeated coronary
angioplasty, or during subsequent coronary artery bypass graft
surgery (CABG). Hospital records were examined to verify
that ECG findings, enzyme test results, and clinical symptoms
were consistent with the Registry definition of MI.
Repeat angioplasty was defined as a procedure performed
during a subsequent hospitalization after the initial coronary
angioplasty. For all lesions attempted at the initial procedure,
target lesion revascularization (TLR) during follow-up was
defined as either repeat coronary angioplasty on the same
lesion, or a graft placed on the native vessel downstream from
the treated lesion. The time at which TLR occurred was
defined as the first time the index lesion was retreated, either
by coronary angioplasty or CABG.
Follow-up. At each participating site, annual telephone
interviews of the patients were conducted by the site coordi-
nator. Information on hospitalizations for MI or repeated
revascularization, angina, and cardiac catheterizations was
collected. At year 10 of follow-up, 1,850 (93.0%) of the
baseline cohort of 1,989 patients were still providing follow-up
information or were known to have died. Of the remaining 139
patients, 93 (4.7%) were lost to follow-up, and 46 (2.3%)
refused to be followed.
Statistical analysis. Patients were grouped by initial coro-
nary angioplasty result (stent-like versus non–stent-like), as
previously defined. Comparisons of long-term patient outcome
were made between the two patient groups, including freedom
from all-cause death (e.g., cardiac and noncardiac mortality
combined), MI, TLR, and repeat revascularization, which
includes intercurrent revascularization for both initially treated
and untreated lesions. The total sample had 75% and 80%
power, respectively (at a 5 0.05), to detect an absolute
difference of 8% (relative difference '40%) in the 10-year rate
of death or MI between the two groups. Assuming 10-year death
and MI rates of 22% and 18%, respectively, in the reference
group (patients with a stent-like result), the absolute difference of
8% corresponds to a clinically meaningful excess of each event
(death or MI) of nearly 1% for each year of follow-up.
Stent-like versus non–stent-like comparisons were also per-
formed in subgroups of patients with single or multivessel
disease. These subgroups were selected because .80% of
patients with single vessel disease were completely revascular-
ized, whereas consistent with earlier reports (19,20), ,40% of
patients with multivessel disease were completely revascular-
ized (irrespective of whether or not a stent-like result was
achieved). Hence, we postulated that if a treatment difference
existed between the stent-like and non–stent-like groups (e.g.,
as a result of the difference in initial lumen gain), it might be
pronounced in patients with single vessel disease.
Differences in mean baseline and angiographic characteris-
tics were analyzed by Student’s t tests when continuous vari-
ables were normally distributed, and by the Wilcoxon rank-sum
test when nonnormality was present. Differences in propor-
tions of categorical variables were assessed by chi-square tests.
Life table analysis by the method of Kaplan-Meier (21) was
used to compare short- and long-term clinical event rates
between the stent-like and non–stent-like groups. Cox regres-
sion analysis (22) was used to assess the relative risk of an
initial stent-like versus non–stent-like result on the occurrence
of clinical events at 10 years of follow-up. The covariates age,
gender, multivessel disease, and initial procedural result (stent-
like versus non–stent-like) were forced to remain in each
model, with stepwise selection performed on other baseline
Abbreviations and Acronyms
CABG 5 coronary artery bypass graft surgery
ECG 5 electrocardiogram
MI 5 myocardial infarction
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factors univariately associated (at p , 0.05) with the clinical
event of interest.
Results
Baseline medical history and initial procedural results.
Overall, 225 of the 1,989 successfully treated patients (11.3%)
achieved an initial stent-like result, with 12.3% of single vessel
disease patients and 10.3% of multivessel disease patients
achieving a stent-like result in at least one coronary vessel
(Table 1). Multiple stent-like results occurred in only 1% of all
patients. Patients who had an MI within 10 d prior to the initial
procedure were less likely to achieve a stent-like result (7.4%
vs. 11.8%, p 5 0.046) compared with those without acute MI.
Patients with single vessel disease and a history of hypercho-
lesterolemia were less likely to achieve a stent-like result (4.7%
vs. 14.4%, p , 0.0001) than those without hypercholesterol-
emia, however, among multivessel disease patients, a reverse
result was seen (7.7% in patients without and 12.7% in patients
with a history of hypercholesterolemia, p 5 0.017).
When multi-lesion coronary angioplasty was performed,
whether within the same or multiple vessels, a stent-like result
occurred more frequently (Table 1). Similarly, completeness of
revascularization was significantly related to whether or not an
initial stent-like result was achieved. Fourteen percent of
patients with complete revascularization had a stent-like result,
whereas only 9% of patients with incomplete revascularization
had an initial stent-like result (Table 1).
Lesion characteristics and initial lesion results. Per lesion
analysis revealed that a stent-like result occurred in 249 of
3,176 attempted lesions (7.8%) and was more frequently
achieved in diffuse lesions (11.2% vs. 7.4%, p 5 0.03), while
less frequently observed in lesions in the right coronary artery
(6.1% vs. 8.5%, p 5 0.02). Although the number of inflations
and maximum balloon inflation pressure applied during the
initial procedure were unrelated to achievement of a stent-like
result, a higher median time of the longest single inflation was
associated with greater likelihood of achieving a stent-like
result (Table 2). The incidence of intimal tear with or without
coronary dissection, as well as severe coronary dissection that,
by definition, raised a portion of the vessel layer and caused an
obstruction or a cessation of blood flow, was unrelated to
whether or not an initial stent-like result was achieved.
Need for target lesion revascularization (TLR). Of 3,176
initially treated lesions, 979 (30.8%) underwent TLR (with
coronary angioplasty and/or CABG) at some time during 10
years of follow-up. Lesions with an initial stent-like result had
a significantly lower incidence of TLR than non–stent-like
result lesions (Fig. 1). The majority of this difference in need
for repeat revascularization occurred within the first 2 years of
follow-up. Overall, 923 of 2,927 (31.5%) non–stent-like result
lesions underwent TLR compared with 56 of 249 (22.5%)
stent-like result lesions (p 5 0.003). These crude rates of TLR
were similar, yet slightly lower than corresponding Kaplan-
Meier estimates of TLR at 10 years of follow-up, which account
for censoring of patients with ,10 years of follow-up (TLR for
non–stent-like lesions 5 34.8%; stent-like result 5 25.0%, p 5
0.004). At a patient rather than lesion level, 649 of 1,764 patients
without an initial stent-like result (36.8%) compared with 68 of
225 patients with an initial stent-like result (30.2%) underwent
TLR at some time during follow-up (p 5 0.06).
Mortality and MI. Table 3 presents Kaplan Meier unto-
ward event rates stratified by stent-like versus non–stent-like
status, and baseline vessel disease. At both short- and long-
term follow-up intervals, the incidence of death, MI, or the
combined end point death/MI was similar between the two
Table 1. Initial Procedural Characteristics and Achievement of
Stent-like Result
Initial Procedural
Characteristic
Frequency and Percent of Patients With a
Stent-like Result Achieved
SVD
Patients
(n 5 973)
MVD
Patients
(n 5 1016)
All
Patients
(n 5 1989)
Overall 120 (12.3) 105 (10.3) 225 (11.3)
Multi-lesion stent-like result 10 (1.0) 12 (1.2) 22 (1.1)
Lesions attempted
Single-lesion attempt 89 (11.5) 31 (7.3) 120 (10.0)
Multi-lesion attempt 31 (15.5) 74 (12.5) 105 (13.3)
p value 0.15 0.009 0.03
Number of diseased vessels
after coronary angioplasty
0 106 (13.2) 39 (15.2) 145 (13.7)
$ 1 14 (8.2) 66 (8.7) 80 (8.6)
p value 0.094 0.004 0.004
MVD 5 multi-vessel disease; SVD 5 single vessel disease.
Table 2. Initial Lesion Results
Initial Procedural Characteristic
Lesions with
SL Result
(n 5 249)
Lesions without
SL Result
(n 5 2,927)
Percent stenosis before first coronary angioplasty
Mean 80.8 81.8
Median 81 85
Percent stenosis after first coronary angioplasty¶
Mean 1.8 30.0
Median 0 30
Total number of inflations
Mean 3.6 3.6
Median 3 3
Maximum inflation pressure (Atm)
Mean 8.4 8.2
Median 8 8
Longest single inflation (s)***
Mean 64.5 56.0
Median 60 58
Severe dissection after dilatation (%)‡ 0.8 1.2
Intimal tear after dilatation (%) 23.3 26.9
SL 5 Stent-like. *p , 0.05, **p , 0.01, ***p , 0.001. ¶No test of significance
was performed since, by definition, lesions with a stent-like result must be #10%
stenosis. ‡Severe dissection by the PTCA catheter that raised a portion of the vessel
layer and caused an obstruction of a cessation of blood flow through the artery.
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patient groups. These findings were consistent in both single
and multivessel disease patients (Fig. 2, Table 3).
Repeat revascularization (by coronary angioplasty or
CABG). The 10-year incidence of any revascularization (by
coronary angioplasty or CABG), which includes re-treatment
of initial attempted lesions (TLR) and first-time treatment of
initially untreated lesions, is presented in Table 3. There was a
nonsignificant trend for patients with multivessel disease and
an initial stent-like result to require less CABG than multives-
sel disease patients without an initial stent-like result (25.2%
vs. 32.7%, p 5 0.09). However, a reverse trend was apparent in
these same patients for the incidence of intercurrent coronary
angioplasty (53.8% vs. 42.7%, p 5 0.07). In patients with
single-vessel disease, the incidence of CABG and intercurrent
coronary angioplasty was similar between patients with and
without an initial stent-like result.
Multivariable analysis. In Cox regression analysis, the
10-year risk of death, death/MI, or repeat coronary angioplasty
Figure 1. Percent of lesions undergoing target lesion re-
vascularization by initial coronary angioplasty result (stent-
like versus non–stent-like result). TLR 5 target lesion
revascularization.
Table 3. Kaplan Meier Untoward Event Rates
Untoward Event
6 months 1 year 5 years 10 years
NSL SL NSL SL NSL SL NSL SL
p
Value
Death
Patients with SVD (n 5 973) 0.8 0.9 1.5 0.9 7.0 5.2 17.1 17.9 0.92
Patients with MVD (n 5 1,016) 1.2 0.0 2.6 1.9 11.1 9.8 27.0 27.1 0.99
All Patients (n 5 1,989) 1.0 0.5 2.1 1.4 9.1 7.3 22.2 22.3 0.93
MI
Patients with SVD 1.3 1.7 2.1 3.4 7.2 7.0 14.0 15.2 0.65
Patients with MVD 1.8 0.0 3.2 2.0 11.4 13.3 21.7 20.6 0.99
All Patients 1.5 0.9 2.7 2.8 9.4 9.9 17.9 17.6 0.87
Death/MI
Patients with SVD 2.0 2.6 3.4 4.3 13.0 12.1 27.6 29.3 0.62
Patients with MVD 2.9 0.0 5.2 3.9 19.9 22.4 40.7 41.7 0.77
All Patients 2.5 1.4 4.3 4.1 16.5 16.9 34.3 35.2 0.70
CABG
Patients with SVD 3.5 4.3 4.9 6.9 9.4 11.4 18.7 21.9 0.45
Patients with MVD 6.3 1.9 9.2 2.9 19.7 12.0 32.7 25.2 0.09
All Patients 5.0 3.2 7.1 5.0 14.2 11.7 25.7 23.3 0.33
Repeat coronary angioplasty
Patients with SVD 16.2 12.0 21.0 15.5 28.4 23.4 38.7 36.1 0.55
Patients with MVD 15.1 15.5 20.8 25.4 32.3 39.3 42.7 53.8 0.07
All Patients 15.6 13.7 20.9 20.1 30.4 30.7 40.7 44.1 0.47
CABG/Repeat coronary angioplasty
Patients with SVD 18.2 12.9 23.7 17.2 33.4 28.8 46.6 45.9 0.68
Patients with MVD 20.2 17.5 27.3 27.3 44.9 44.2 60.2 62.2 0.94
All Patients 19.2 15.1 25.5 21.9 39.3 35.9 53.5 53.4 0.65
MVD 5 multi-vessel disease; NSL 5 initial non–stent-like result; SL 5 initial stent-like result; SVD 5 single-vessel
disease; p value is for log-rank test over 10 years of follow-up.
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was unrelated to whether or not a stent-like result was
achieved at the initial coronary angioplasty. After adjustment
for age, gender, vessel disease, and other significant baseline
factors, there was a nonsignificant trend for patients with an
initial stent-like result to be at lower risk of 10-year CABG
(relative risk 5 0.77, 95% confidence interval 5 0.55, 1.08, p 5
0.13) and 10-year TLR (relative risk 5 0.79, 95% confidence
interval 5 0.60, 1.05, p 5 0.11).
Discussion
We compared the long-term outcome of patients with
successful conventional dilatation on the basis of whether or
not an initial “stent-like” result was achieved. Overall, patients
with an initial stent-like result were more completely revascu-
larized (irrespective of baseline vessel disease) than non–stent-
like result patients. Although a stent-like result occurred more
often in diffuse lesions, we suspect this may relate to the
selection of proximal and distal segments (averaged) to deter-
mine reference (“normal”) diameter. If either (or both) of the
reference segments included diseased areas, then the reference
lumen would be reduced, thereby making a stent-like result
more probable.
Repeat revascularization. In per-lesion analysis, the larger
gain in lumen achieved in lesions with an initial stent-like result
corresponded to a markedly lower incidence of TLR, particularly
in the first 2 years of follow-up. This finding is consistent with
results from the BENESTENT (4) and STRESS (5) trials, where
the incidence of lesion restenosis was significantly lower after
coronary stenting than after coronary angioplasty. Similarly, on a
patient level, the group of patients with a stent-like result had a
better long-term outcome in terms of repeat revascularization.
This included less need for TLR and a decreased incidence of
CABG. In these patients if repeat revascularization was required,
repeat dilatation was more frequently performed.
The importance of achieving an initial excellent angio-
graphic result has been emphasized (8). Following treatment,
the development of neo-intimal hyperplasia and arterial con-
traction is better tolerated if the initial gain in lumen is large.
Stents have been proven to be the most reliable technique to
achieve an initial excellent result with a residual stenosis
,10%. However, the use of stents has not solved all the
problems. Indeed, stents increase the amount of neo-intimal
hyperplasia even though they do decrease TLR. Effective
treatments for diffuse in-stent restenosis have not been iden-
tified. In addition, stents are costly, particularly when multiple
stents are required in the setting of multivessel disease. For
these reasons, there is a rebirth of interest in optimizing
conventional coronary angioplasty. In the OCBAS trial (23),
the rate of restenosis and target vessel revascularization at 7.6
months was similar between stented patients and those with an
optimal result obtained with conventional coronary angio-
plasty. The approach of optimizing the initial results and only
placing the stent if the initial result is not optimal is called
“provisional stenting.” There are limited long-term data on
patients with a stent-like result with conventional coronary
angioplasty. In the 1985–86 NHLBI PTCA Registry, a stent-
like result was achieved in only 11% of successfully treated
patients, as determined by visual assessment. Nonetheless,
there was a definite relationship between achieving a stent-like
result and multi-lesion dilatation. This probably was a result of
the fact that the operators were encouraged to continue
sequentially during a procedure when the results were ideal.
Death and MI. Despite the more complete revasculariza-
tion and lower incidence of TLR in patients with an initial
stent-like result, the long-term risk of MI or death was
unaffected by whether or not an initial stent-like result was
achieved. One factor that may contribute to this apparent lack
of difference stems from the fact that stability of atheroscle-
rotic lesions and potential for rupture and subsequent infarc-
tion may be unrelated to the severity of lesion stenosis (24,25).
In both the stent-like and non–stent-like patient groups, not all
significant lesions were dilated at the initial coronary angio-
plasty, and further, virtually all lesions ,50% stenosis were not
dilated. Therefore, there was a substantial pool of initially
untreated lesions, varying in degree of stenoses, in both the
stent-like and non–stent-like patient groups. It is possible that
a similar proportion of the untreated lesions within each group
(stent-like vs. non–stent-like) had the potential for rupture and
subsequent MI and/or sudden cardiac death. Our findings of
Figure 2. Ten-year mortality rate by vessel disease (single
versus multi-vessel) and initial coronary angioplasty result
(stent-like versus non–stent-like result). SVD 5 single-
vessel disease; MVD 5 multi-vessel disease; NSL 5 non–
stent-like result; SL 5 stent-like result.
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comparable long-term mortality and incidence of MI between
the stent-like and non–stent-like patient groups are consistent
with shorter term (6 month to 1 year) randomized trial
comparisons of mortality and MI rates between patients
assigned to conventional coronary angioplasty and those re-
ceiving stents (4–7).
Limitations. Patients in the Registry were treated in
1985–86 prior to recent technical refinements in balloon
catheters. We cannot speculate as to whether similar results
would be seen from patients being treated today. In addition,
the assessment of postdilatation stenosis was determined by
visual assessment. Quantitative coronary angiography is known
to be more reliable than visual interpretation of coronary
angiograms (26), although visual assessment is the method
most commonly used in clinical practice. The use of visual
assessment in this study may have resulted in some misclassi-
fication in terms of patients who did, or did not, achieve an
initial stent-like result. We purposely selected a stringent
definition of a stent-like result (#10% stenosis) to maximize
the likelihood that patients deemed to have had a stent-like
result, by visual assessment, truly did achieve an optimal result.
In the registry, 7.8% of all attempted lesions were considered
to have achieved a stent-like result (Table 2). This compares
with 8.5% of de novo lesions treated with conventional coro-
nary angioplasty, and assessed by a core angiographic labora-
tory (Stanford University), in 904 randomized patients (2,252
lesions) in the Bypass Angioplasty Revascularization Investi-
gation (K. Kip, personal communications). The similarity
between these two studies would suggest reasonable visual
assessment reliability in the PTCA Registry determination of
an initial optimal (stent-like) result.
Conclusions. In this study of 1,989 patients who underwent
de novo coronary angioplasty in 1985–86, an initial stent-like
result achieved with coronary angioplasty alone did not influ-
ence the long-term risk of death or MI. However, a stent-like
result was associated with less TLR, particularly within the first
2 years of follow-up. Among patients with multivessel disease,
those with an initial stent-like result (vs. those without) were
less likely to undergo CABG, yet more likely to undergo repeat
coronary angioplasty when repeat revascularization was re-
quired. Achieving a stent-like result with balloon angioplasty
alone may not confer equivalent clinical benefit as achieving a
stent-like result with a stent. Whether or not “provisional
stenting” (e.g., in cases of suboptimal dilatation) rather than
primary intracoronary stenting should be recommended re-
mains to be determined.
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